PROTECT-TIMI 30

PROTECT-TIMI 30 evaluated the angiographic efficacy of bivalirudin vs eptifibatide for coronary stenting.

DOWNLOAD SLIDE SET (PDF)

Key Study Publications

Gibson, C. M., Morrow, D. A., Murphy, S. A., Palabrica, T. M., Jennings, L. K., Stone, P. H., Lui, H. H., Bulle, T., Lakkis, N., Kovach, R., Cohen, D. J., Fish, P., McCabe, C. H., Braunwald, E. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial J Am Coll Cardiol. 2006;47(12):2364-73.